This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| DNAJC5 | |
|---|---|
| Name | DnaJ homolog subfamily C member 5 |
| Organism | Homo sapiens |
| Synonyms | CSPα; CSP |
| Entrez | 8440 |
| Uniprot | O43765 |
| Chromosome | 20 |
| Location | 20p13 |
DNAJC5
DNAJC5 is a human gene encoding DnaJ homolog subfamily C member 5, a synaptic vesicle-associated co-chaperone implicated in presynaptic proteostasis and neurodegeneration. It was characterized in studies linking synaptic function to protein homeostasis and is notable for mutations that cause adult-onset neuronal ceroid lipofuscinosis. The protein participates in membrane trafficking, client protein folding, and protection against aggregation in neuronal and endocrine secretory pathways.
DNAJC5 functions as a co-chaperone that regulates client proteins in the presynaptic compartment through interactions with heat shock proteins and vesicle-associated machinery. In neurons it modulates synaptic vesicle exocytosis and endocytosis by cooperating with HSPA family members, and it contributes to the maintenance of SNARE complex components and voltage-gated ion channels. Loss or mutation of DNAJC5 impairs neurotransmitter release and axonal integrity, accelerating proteostatic stress pathways studied in research on Parkinsonism, Alzheimer disease, and lysosomal storage disorders.
The encoded protein contains an N-terminal membrane-anchoring cysteine string domain that undergoes palmitoylation, a central J-domain characteristic of DnaJ/Hsp40 co-chaperones, and a C-terminal substrate-binding region. The J-domain mediates interaction with HSPA family ATPases to stimulate ATPase activity, while the cysteine-rich motif targets the protein to secretory vesicles through lipid modifications. Structural studies and domain mapping have informed mechanisms of client recruitment and oligomerization relevant to synaptic vesicle biology.
DNAJC5 is highly expressed in neuronal tissues, including cerebral cortex, hippocampus, cerebellum, and peripheral ganglia, with additional expression in endocrine tissues such as pancreatic islets and adrenal medulla. Subcellular localization is predominantly to synaptic vesicles, presynaptic terminals, and secretory granules, with dynamic relocalization during neuronal activity. Expression patterns have been mapped using models ranging from mouse brain atlases to human postmortem studies and in vitro neuronal cultures derived from induced pluripotent stem cells.
Mutations in DNAJC5 are causative for adult-onset neuronal ceroid lipofuscinosis (ANCL), also known as Parry disease in some reports, leading to progressive neurodegeneration, myoclonus, epilepsy, and cognitive decline. Genetic variants affecting the cysteine string domain disrupt palmitoylation and membrane targeting, resulting in lipofuscin accumulation, lysosomal dysfunction, and synaptic failure. DNAJC5-related pathology has been investigated in the context of Huntington disease, frontotemporal dementia, and Parkinson disease to elucidate convergent mechanisms of protein aggregation and lysosomal impairment. Diagnostic genetic testing and genotype-phenotype correlations have been reported in clinical cohorts, and the gene is a target in therapeutic research exploring chaperone-mediated strategies and autophagy modulation.
DNAJC5 interacts with multiple proteins and complexes central to synaptic function and proteostasis, including HSPA8, HSPA1A, syntaxin family members, SNAP25, synaptotagmin, and components of the endosomal-lysosomal system. It forms functional assemblies with cysteine string protein-interacting partners identified in proteomic screens and co-immunoprecipitation studies from rodent brain and human neuronal models. These interactions connect DNAJC5 to pathways studied by researchers of synaptic biology, vesicle trafficking, and neurodegenerative disease mechanisms.
Mouse knockout and knock-in models have recapitulated neurodegenerative phenotypes, synaptic dysfunction, and accumulation of autofluorescent storage material, providing insight into disease progression and enabling preclinical testing of chaperone-enhancing and autophagy-targeting interventions. Drosophila ortholog studies revealed essential roles in neurotransmission and lifespan, while zebrafish and C. elegans models contributed to high-throughput genetic and chemical screens. Cellular models, including patient-derived induced pluripotent stem cell neurons and primary rodent neurons, have been employed to study palmitoylation dynamics, aggregation propensity, and rescue strategies using molecular chaperones, gene replacement, and small-molecule modulators.
Category:Human genes